NIPH Clinical Trials Search

JAPANESE
国立保健医療科学院
JAPIC ID: JapicCTI-111534

Registered date:

Basic Information

Recruitment status
Health condition(s) or Problem(s) studiedHypervascular tumors or arteriovenous malformations
Date of first enrollment
Target sample size25
Countries of recruitment
Study typeINTERVENTIONAL
Intervention(s)Intervention name : NK938 Dosage And administration of the intervention : Intraarterial Control intervention name : null

Outcome(s)

Primary OutcomeEmbolize or marked blood flow reduction to the artery Success rate of embolization
Secondary OutcomeClinical effect

Key inclusion & exclusion criteria

Age minimum20
Age maximum
GenderBOTH
Include criteriaPatients who are clinically diagnosed as having hypervascular tumors or arteriovenous malformations.
Exclude criteriaIn large diameter arteriovenous shunts

Related Information

Contact

public contact
Name Nippon Kayaku Co., Ltd. Pharmaceutical Development Division, Clinical Development
Address FAX 81-3-3598-5423
Telephone
E-mail
Affiliation
scientific contact
Name
Address
Telephone
E-mail
Affiliation